annual CFO:
-$33.89M+$35.20M(+50.95%)Summary
- As of today (September 17, 2025), FOLD annual cash flow from operations is -$33.89 million, with the most recent change of +$35.20 million (+50.95%) on December 31, 2024.
- During the last 3 years, FOLD annual CFO has risen by +$168.60 million (+83.26%).
- FOLD annual CFO is now -323.08% below its all-time high of $15.19 million, reached on December 31, 2007.
Performance
FOLD Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$26.53M-$34.28M(-441.92%)Summary
- As of today (September 17, 2025), FOLD quarterly cash flow from operations is -$26.53 million, with the most recent change of -$34.28 million (-441.92%) on June 30, 2025.
- Over the past year, FOLD quarterly CFO has dropped by -$49.22 million (-216.90%).
- FOLD quarterly CFO is now -162.54% below its all-time high of $42.41 million, reached on December 31, 2007.
Performance
FOLD quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$45.66M-$49.22M(-1381.72%)Summary
- As of today (September 17, 2025), FOLD TTM cash flow from operations is -$45.66 million, with the most recent change of -$49.22 million (-1381.72%) on June 30, 2025.
- Over the past year, FOLD TTM CFO has dropped by -$3.76 million (-8.98%).
- FOLD TTM CFO is now -313.66% below its all-time high of $21.37 million, reached on June 30, 2008.
Performance
FOLD TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
FOLD Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.0% | -216.9% | -9.0% |
| 3 y3 years | +83.3% | -67.2% | +72.9% |
| 5 y5 years | +86.5% | +20.9% | +82.1% |
FOLD Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +83.3% | -216.9% | +67.2% | -1381.7% | +72.9% |
| 5 y | 5-year | at high | +86.5% | -216.9% | +67.2% | -1381.7% | +82.1% |
| alltime | all time | -323.1% | +88.7% | -162.5% | +80.0% | -313.7% | +86.2% |
FOLD Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$26.53M(-441.9%) | -$45.66M(-1381.7%) |
| Mar 2025 | - | $7.76M(-298.1%) | $3.56M(-110.5%) |
| Dec 2024 | -$33.89M(-50.9%) | -$3.92M(-83.0%) | -$33.89M(+27.8%) |
| Sep 2024 | - | -$22.97M(-201.2%) | -$26.52M(-36.7%) |
| Jun 2024 | - | $22.69M(-176.4%) | -$41.89M(-48.1%) |
| Mar 2024 | - | -$29.70M(-958.7%) | -$80.72M(+16.8%) |
| Dec 2023 | -$69.09M(-58.5%) | $3.46M(-109.0%) | -$69.09M(-54.9%) |
| Sep 2023 | - | -$38.35M(+137.7%) | -$153.32M(+21.1%) |
| Jun 2023 | - | -$16.13M(-10.7%) | -$126.60M(+0.2%) |
| Mar 2023 | - | -$18.07M(-77.6%) | -$126.33M(-24.2%) |
| Dec 2022 | -$166.57M(-17.7%) | -$80.77M(+594.8%) | -$166.57M(+6.6%) |
| Sep 2022 | - | -$11.63M(-26.7%) | -$156.32M(-7.2%) |
| Jun 2022 | - | -$15.86M(-72.8%) | -$168.39M(-10.6%) |
| Mar 2022 | - | -$58.31M(-17.3%) | -$188.45M(-6.9%) |
| Dec 2021 | -$202.49M(-13.2%) | -$70.51M(+197.5%) | -$202.49M(+11.4%) |
| Sep 2021 | - | -$23.70M(-34.0%) | -$181.80M(-9.1%) |
| Jun 2021 | - | -$35.92M(-50.4%) | -$200.11M(+1.2%) |
| Mar 2021 | - | -$72.35M(+45.2%) | -$197.70M(-15.3%) |
| Dec 2020 | -$233.29M(-6.8%) | -$49.82M(+18.6%) | -$233.29M(-3.3%) |
| Sep 2020 | - | -$42.01M(+25.3%) | -$241.30M(-5.3%) |
| Jun 2020 | - | -$33.52M(-68.9%) | -$254.84M(-8.9%) |
| Mar 2020 | - | -$107.94M(+86.6%) | -$279.81M(+11.7%) |
| Dec 2019 | -$250.42M(-16.5%) | -$57.83M(+4.1%) | -$250.42M(-1.1%) |
| Sep 2019 | - | -$55.55M(-5.0%) | -$253.26M(-23.4%) |
| Jun 2019 | - | -$58.48M(-25.5%) | -$330.47M(+0.5%) |
| Mar 2019 | - | -$78.55M(+29.4%) | -$328.98M(+9.7%) |
| Dec 2018 | -$299.95M(+39.2%) | -$60.68M(-54.3%) | -$299.95M(-4.2%) |
| Sep 2018 | - | -$132.76M(+132.9%) | -$313.02M(+36.0%) |
| Jun 2018 | - | -$56.99M(+15.1%) | -$230.22M(+7.0%) |
| Mar 2018 | - | -$49.52M(-32.8%) | -$215.13M(-0.2%) |
| Dec 2017 | -$215.49M(+43.1%) | -$73.74M(+47.6%) | -$215.49M(+24.0%) |
| Sep 2017 | - | -$49.96M(+19.2%) | -$173.73M(+5.5%) |
| Jun 2017 | - | -$41.91M(-16.0%) | -$164.65M(+5.9%) |
| Mar 2017 | - | -$49.87M(+55.9%) | -$155.47M(+3.3%) |
| Dec 2016 | -$150.53M(+50.3%) | -$31.98M(-21.8%) | -$150.53M(-2.3%) |
| Sep 2016 | - | -$40.88M(+24.9%) | -$154.06M(+14.8%) |
| Jun 2016 | - | -$32.73M(-27.2%) | -$134.20M(+8.1%) |
| Mar 2016 | - | -$44.94M(+26.5%) | -$124.10M(+23.9%) |
| Dec 2015 | -$100.14M | -$35.51M(+69.0%) | -$100.14M(+26.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | -$21.02M(-7.2%) | -$79.14M(+8.0%) |
| Jun 2015 | - | -$22.64M(+7.9%) | -$73.24M(+17.3%) |
| Mar 2015 | - | -$20.98M(+44.6%) | -$62.42M(+20.8%) |
| Dec 2014 | -$51.67M(+12.8%) | -$14.51M(-4.1%) | -$51.67M(+14.1%) |
| Sep 2014 | - | -$15.12M(+27.9%) | -$45.28M(+3.7%) |
| Jun 2014 | - | -$11.82M(+15.6%) | -$43.67M(+3.7%) |
| Mar 2014 | - | -$10.22M(+25.9%) | -$42.11M(-8.0%) |
| Dec 2013 | -$45.79M(+35.7%) | -$8.12M(-39.9%) | -$45.79M(+1.7%) |
| Sep 2013 | - | -$13.51M(+31.7%) | -$45.05M(+16.3%) |
| Jun 2013 | - | -$10.26M(-26.2%) | -$38.73M(-2.2%) |
| Mar 2013 | - | -$13.90M(+88.5%) | -$39.60M(+17.4%) |
| Dec 2012 | -$33.74M(-31.7%) | -$7.37M(+2.4%) | -$33.74M(-13.2%) |
| Sep 2012 | - | -$7.20M(-35.3%) | -$38.89M(-13.0%) |
| Jun 2012 | - | -$11.13M(+38.5%) | -$44.68M(+1.2%) |
| Mar 2012 | - | -$8.04M(-35.8%) | -$44.16M(-10.7%) |
| Dec 2011 | -$49.42M(+253.4%) | -$12.52M(-3.6%) | -$49.42M(+240.0%) |
| Sep 2011 | - | -$12.99M(+22.4%) | -$14.54M(+15.3%) |
| Jun 2011 | - | -$10.61M(-20.3%) | -$12.61M(-9.0%) |
| Mar 2011 | - | -$13.31M(-159.5%) | -$13.86M(-0.9%) |
| Dec 2010 | -$13.98M(-67.8%) | $22.36M(-302.2%) | -$13.98M(-70.2%) |
| Sep 2010 | - | -$11.06M(-6.7%) | -$46.94M(-0.9%) |
| Jun 2010 | - | -$11.86M(-11.7%) | -$47.35M(+3.0%) |
| Mar 2010 | - | -$13.43M(+26.8%) | -$45.95M(+5.9%) |
| Dec 2009 | -$43.37M(+17.7%) | -$10.59M(-7.7%) | -$43.37M(-7.9%) |
| Sep 2009 | - | -$11.47M(+9.7%) | -$47.08M(+8.9%) |
| Jun 2009 | - | -$10.46M(-3.6%) | -$43.23M(+6.7%) |
| Mar 2009 | - | -$10.85M(-24.1%) | -$40.52M(+9.9%) |
| Dec 2008 | -$36.86M(-342.6%) | -$14.30M(+87.5%) | -$36.86M(-285.7%) |
| Sep 2008 | - | -$7.63M(-1.5%) | $19.85M(-7.1%) |
| Jun 2008 | - | -$7.74M(+7.6%) | $21.37M(+14.1%) |
| Mar 2008 | - | -$7.20M(-117.0%) | $18.73M(+23.3%) |
| Dec 2007 | $15.19M(-144.8%) | $42.41M(-794.8%) | $15.19M(-155.8%) |
| Sep 2007 | - | -$6.10M(-41.2%) | -$27.22M(+28.9%) |
| Jun 2007 | - | -$10.38M(-3.3%) | -$21.12M(+96.7%) |
| Mar 2007 | - | -$10.74M | -$10.74M |
| Dec 2006 | -$33.89M(+87.0%) | - | - |
| Dec 2005 | -$18.12M(+96.3%) | - | - |
| Dec 2004 | -$9.23M(+138.1%) | - | - |
| Dec 2003 | -$3.88M | - | - |
FAQ
- What is Amicus Therapeutics, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. annual CFO year-on-year change?
- What is Amicus Therapeutics, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. quarterly CFO year-on-year change?
- What is Amicus Therapeutics, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. TTM CFO year-on-year change?
What is Amicus Therapeutics, Inc. annual cash flow from operations?
The current annual CFO of FOLD is -$33.89M
What is the all time high annual CFO for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high annual cash flow from operations is $15.19M
What is Amicus Therapeutics, Inc. annual CFO year-on-year change?
Over the past year, FOLD annual cash flow from operations has changed by +$35.20M (+50.95%)
What is Amicus Therapeutics, Inc. quarterly cash flow from operations?
The current quarterly CFO of FOLD is -$26.53M
What is the all time high quarterly CFO for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high quarterly cash flow from operations is $42.41M
What is Amicus Therapeutics, Inc. quarterly CFO year-on-year change?
Over the past year, FOLD quarterly cash flow from operations has changed by -$49.22M (-216.90%)
What is Amicus Therapeutics, Inc. TTM cash flow from operations?
The current TTM CFO of FOLD is -$45.66M
What is the all time high TTM CFO for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high TTM cash flow from operations is $21.37M
What is Amicus Therapeutics, Inc. TTM CFO year-on-year change?
Over the past year, FOLD TTM cash flow from operations has changed by -$3.76M (-8.98%)